U.S. Markets closed

Fulgent Genetics, Inc. (FLGT)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
74.64+1.63 (+2.23%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close73.01
Open73.72
Bid73.87 x 800
Ask75.00 x 900
Day's Range73.54 - 77.32
52 Week Range8.90 - 189.89
Volume2,502,713
Avg. Volume2,088,781
Market Cap2.164B
Beta (5Y Monthly)1.62
PE Ratio (TTM)8.38
EPS (TTM)8.91
Earnings DateMay 06, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est89.00
  • Why Investors Loved Fulgent Genetics' Q1 Results
    Motley Fool

    Why Investors Loved Fulgent Genetics' Q1 Results

    Investors might have begun to worry that Fulgent Genetics' (NASDAQ: FLGT) freefall in recent months would never end. The genetic testing company's shares have plunged more than 50% from the highs set earlier this year. Fulgent announced its first-quarter results after the market closed Thursday.

  • Fulgent Genetics, Inc. Common Stock (FLGT) Q1 2021 Earnings Call Transcript
    Motley Fool

    Fulgent Genetics, Inc. Common Stock (FLGT) Q1 2021 Earnings Call Transcript

    At this time, I would like to turn the conference over to Nicole Borsje with investor relations. On the call today are Ming Hsieh, chief executive officer; Paul Kim, chief financial officer; and Brandon Perthuis, chief commercial officer.

  • Business Wire

    Fulgent Genetics Reports Record First Quarter Financial Results

    Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent" or the "company"), a technology company providing large-scale COVID-19 testing services and comprehensive testing solutions through its scalable technology platform, today announced financial results for its first quarter ended March 31, 2021.